Literature DB >> 9248875

Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.

S Foster1, J Kessel, M E Berman, G M Simpson.   

Abstract

The efficacy of a benzodiazepine was compared with that of a neuroleptic for the rapid tranquilization of patients presenting at a psychiatric emergency room service. Thirty-seven highly agitated patients exhibiting psychotic symptoms were randomly assigned to receive either 2 mg lorazepam or 5 mg haloperidol as needed every 30 min for 4 h. Administration route was either intramuscular injection or oral concentrate. Symptom ratings were conducted each hour using double-blind procedures. Both medications reduced symptom ratings on the Brief Psychiatric Rating Scale and Global Clinical Impression of Overall Symptom Severity Scale. Global Clinical Impression scores for the two medication groups did not differ significantly either at baseline or at 4 h after entry into the study. However, Global Clinical Impression scores of patients in the lorazepam group were less severe at intermittent ratings. The groups did not differ on the Brief Psychiatric Rating Scale at any rating time. No differences were found either in the number of doses administered or in the administration route selected. Given the potential for severe extrapyramidal symptoms developing hours or days after a single dose of haloperidol, lorazepam may provide an excellent alternative for the rapid tranquilization of the acutely agitated psychotic patient in the emergency room setting.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248875     DOI: 10.1097/00004850-199705000-00009

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  20 in total

1.  Rapid Tranquilization for Psychiatric Patients with Psychomotor Agitation: What is Known About it?

Authors:  Clayton Gonçalves de Almeida; Mariana Del Grossi Moura; Silvio Barberato-Filho; Fernando de Sá Del Fiol; Rogério Heládio Lopes Motta; Cristiane de Cássia Bergamaschi
Journal:  Psychiatr Q       Date:  2017-12

Review 2.  [Psychotropic agents in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-02       Impact factor: 0.840

Review 3.  Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Melanie J Brooke-Powney; Xue Li; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

4.  Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.

Authors:  Shlomo Brook; Jeorg Walden; Isma Benattia; Cynthia O Siu; Steven J Romano
Journal:  Psychopharmacology (Berl)       Date:  2005-01-14       Impact factor: 4.530

Review 5.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Pharmacological management of agitation in emergency settings.

Authors:  A Yildiz; G S Sachs; A Turgay
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

Review 7.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

Review 8.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 9.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  [Psychopharmacological treatment in the pre-clinical emergency medicine].

Authors:  F-G Pajonk; B Fleiter
Journal:  Anaesthesist       Date:  2003-07-10       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.